1. Volume 87, Issue 1, Pages 225-232 (January 2015)
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment 
Norishige Yoshikawa, Koichi Nakanishi, Mayumi Sako, Mari S. Oba, Rintaro Mori, Erika Ota, Kenji Ishikura, Hiroshi Hataya, Masataka Honda, Shuichi Ito, Yuko Shima, Hiroshi Kaito, Kandai Nozu, Hidefumi Nakamura, Takashi Igarashi, Yasuo Ohashi, Kazumoto Iijima 
Kidney International 
Volume 87, Issue 1, Pages (January 2015)
DOI: /ki
Copyright © 2015 International Society of Nephrology Terms and Conditions

2. Figure 1
Trial profile.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

3. Figure 2
Kaplan–Meier estimates of time to frequently relapsing nephrotic syndrome (FRNS). HR, hazard ratio.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

4. Figure 3
Kaplan–Meier estimates of time to first relapse. HR, hazard ratio.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

5. Figure 4
Initial treatment regimens. Upper doses are in mg/m2 per day. Maximum doses are in mg/day. D, daily; AD, alternate days.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions

6. Figure 5
Treatment regimens for relapse.aUntil urinary protein is negative on 3 consecutive days using a urine dipstick test. Upper doses are in mg/m2/day. A maximum dose of each is the same as initial treatments in Figure 4. AD, alternate days; D, daily.
Kidney International  , DOI: ( /ki )
Copyright © 2015 International Society of Nephrology Terms and Conditions